Rani Therapeutics (RANI) News Today $2.05 -0.01 (-0.49%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period RANI: Third Quarter UpdateNovember 21 at 2:08 AM | finance.yahoo.comRani Therapeutics Advances in Biotherapeutics MarketNovember 19 at 11:32 AM | markets.businessinsider.comRani Therapeutics Holdings: Buy Rating Backed by Strong Financial Outlook and Strategic Focus on RT-114 ProgramNovember 19 at 11:32 AM | markets.businessinsider.comHC Wainwright Reiterates "Buy" Rating for Rani Therapeutics (NASDAQ:RANI)HC Wainwright restated a "buy" rating and issued a $9.00 price objective on shares of Rani Therapeutics in a research report on Tuesday.November 19 at 8:34 AM | marketbeat.comMaxim Group Remains a Buy on Rani Therapeutics Holdings (RANI)November 15, 2024 | markets.businessinsider.comRani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate UpdateNovember 14, 2024 | markets.businessinsider.comRani Therapeutics Holdings Inc Class A RANINovember 10, 2024 | morningstar.comRani Therapeutics Holdings options imply 12.6% move in share price post-earningsNovember 10, 2024 | markets.businessinsider.comRani Therapeutics to Participate in Upcoming Investor ConferencesNovember 8, 2024 | finance.yahoo.comRani Therapeutics Holdings, Inc. (NASDAQ:RANI) Given Average Recommendation of "Buy" by AnalystsShares of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI - Get Free Report) have been given a consensus recommendation of "Buy" by the seven research firms that are covering the company, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating and one has given a stOctober 31, 2024 | marketbeat.comRani Therapeutics Holdings, Inc. (NASDAQ:RANI) Sees Significant Growth in Short InterestRani Therapeutics Holdings, Inc. (NASDAQ:RANI - Get Free Report) saw a significant growth in short interest in the month of October. As of October 15th, there was short interest totalling 2,550,000 shares, a growth of 223.4% from the September 30th total of 788,600 shares. Based on an average daily volume of 1,480,000 shares, the short-interest ratio is presently 1.7 days. Approximately 12.3% of the shares of the company are short sold.October 25, 2024 | marketbeat.comRANI: New Triagonist Data in Weight LossOctober 22, 2024 | msn.comRani Therapeutics: Innovative Oral Delivery System and Promising Obesity Treatment Potential Support Buy RatingOctober 22, 2024 | markets.businessinsider.comBuy Rating Affirmed for Rani Therapeutics: Promising Developments in Oral Obesity Treatment with RaniPill™October 19, 2024 | markets.businessinsider.comBuy Rating Affirmed for Rani Therapeutics: Promising Developments in Oral Obesity Treatment with RaniPill™October 19, 2024 | markets.businessinsider.comRani Therapeutics (NASDAQ:RANI) Earns "Buy" Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $9.00 price target on shares of Rani Therapeutics in a research note on Friday.October 18, 2024 | marketbeat.comRani Therapeutics Holdings, Inc. (NASDAQ:RANI) Major Shareholder Sells $10,147,804.00 in StockOctober 18, 2024 | insidertrades.comRani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin TriagonistOctober 17, 2024 | markets.businessinsider.comRani Therapeutics Holdings, Inc. (NASDAQ:RANI) Major Shareholder South Cone Investments Limited Sells 3,829,360 SharesRani Therapeutics Holdings, Inc. (NASDAQ:RANI - Get Free Report) major shareholder South Cone Investments Limited sold 3,829,360 shares of the stock in a transaction on Tuesday, October 15th. The stock was sold at an average price of $2.65, for a total value of $10,147,804.00. Following the completion of the sale, the insider now owns 8,302,194 shares of the company's stock, valued at $22,000,814.10. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Large shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.October 17, 2024 | marketbeat.com3 Penny Stocks to Watch Now, 10/15/24October 16, 2024 | msn.comWhy Rani Therapeutics Shares Are Down 23% TodayOctober 16, 2024 | benzinga.comRani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing WarrantsOctober 15, 2024 | globenewswire.comOppenheimer Predicts up to 740% Rally for These 2 ‘Strong Buy’ StocksOctober 12, 2024 | markets.businessinsider.comRani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual SummitOctober 8, 2024 | globenewswire.comRani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Average Rating of "Buy" from BrokeragesRani Therapeutics Holdings, Inc. (NASDAQ:RANI - Get Free Report) has earned an average recommendation of "Buy" from the seven analysts that are presently covering the stock, Marketbeat reports. Six investment analysts have rated the stock with a buy recommendation and one has issued a strong buyOctober 6, 2024 | marketbeat.comRani Therapeutics Hldgs (NASDAQ:RANI) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comRani Therapeutics (NASDAQ:RANI) Shares Down 4.3% Rani Therapeutics (NASDAQ:RANI) Trading Down 4.3%October 3, 2024 | marketbeat.comRani Therapeutics to Participate in September Investor ConferencesSeptember 3, 2024 | globenewswire.comChemomab Therapeutics: Strong Buy Rating on Robust Financials and Positive Clinical Trial OutcomesAugust 23, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: BioCardia (BCDA) and CytomX Therapeutics (CTMX)August 22, 2024 | markets.businessinsider.comRani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Average Rating of "Buy" from AnalystsShares of Rani Therapeutics Holdings, Inc. (NASDAQ:RANI - Get Free Report) have received a consensus recommendation of "Buy" from the eight brokerages that are currently covering the firm, Marketbeat reports. Seven analysts have rated the stock with a buy recommendation and one has given a strongAugust 17, 2024 | marketbeat.comLykos to cut 75% of workforce, founder to exit board after drug setbackAugust 16, 2024 | msn.comHC Wainwright Lowers Rani Therapeutics (NASDAQ:RANI) Price Target to $9.00HC Wainwright dropped their target price on Rani Therapeutics from $13.00 to $9.00 and set a "buy" rating on the stock in a report on Friday.August 16, 2024 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Hoth Therapeutics (HOTH), Rewalk Robotics (LFWD) and Rani Therapeutics Holdings (RANI)August 16, 2024 | markets.businessinsider.comFY2024 EPS Estimates for Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Reduced by AnalystRani Therapeutics Holdings, Inc. (NASDAQ:RANI - Free Report) - Analysts at Cantor Fitzgerald reduced their FY2024 earnings per share (EPS) estimates for shares of Rani Therapeutics in a report released on Monday, August 12th. Cantor Fitzgerald analyst O. Brayer now anticipates that the company wiAugust 14, 2024 | marketbeat.comXLerator Network Selects 8 Life Science Startups Across Southeast for NIH-Funded Entrepreneurship Program: I-RED's Second Cohort AnnouncedAugust 14, 2024 | finance.yahoo.comRANI: Second Quarter ResultsAugust 12, 2024 | msn.comInnovative Oral Delivery Platform Drives Buy Rating for Rani Therapeutics HoldingsAugust 9, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Lumos Pharma (LUMO) and Rani Therapeutics Holdings (RANI)August 7, 2024 | markets.businessinsider.comRani Therapeutics (NASDAQ:RANI) Posts Quarterly Earnings Results, Beats Expectations By $0.03 EPSRani Therapeutics (NASDAQ:RANI - Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.26) EPS for the quarter, beating analysts' consensus estimates of ($0.29) by $0.03.August 7, 2024 | marketbeat.comRani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate UpdateAugust 7, 2024 | finance.yahoo.comOppenheimer Initiates Coverage of Rani Therapeutics Holdings (RANI) with Outperform RecommendationAugust 3, 2024 | msn.comRani Therapeutics to Participate in August Investor ConferencesJuly 29, 2024 | globenewswire.comRani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Average Recommendation of "Buy" from AnalystsRani Therapeutics Holdings, Inc. (NASDAQ:RANI - Get Free Report) has been assigned an average rating of "Buy" from the seven brokerages that are covering the company, Marketbeat.com reports. Six research analysts have rated the stock with a buy rating and one has assigned a strong buy rating toJuly 23, 2024 | marketbeat.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Astellas Pharma (OtherALPMF) and Verona Pharma (VRNA)July 22, 2024 | markets.businessinsider.comRani Therapeutics prices securities offering to raise $10 millionJuly 22, 2024 | msn.comRani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct OfferingJuly 22, 2024 | globenewswire.comRani Therapeutics Holdings, Inc. (NASDAQ:RANI) Receives Consensus Recommendation of "Buy" from AnalystsRani Therapeutics Holdings, Inc. (NASDAQ:RANI - Get Free Report) has been assigned an average rating of "Buy" from the eight ratings firms that are presently covering the company, MarketBeat.com reports. Seven equities research analysts have rated the stock with a buy rating and one has assignedJune 28, 2024 | marketbeat.comRani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity TreatmentJune 24, 2024 | globenewswire.comRani Therapeutics (NASDAQ:RANI) Raised to Strong-Buy at Maxim GroupMaxim Group upgraded shares of Rani Therapeutics to a "strong-buy" rating in a research note on Thursday.June 15, 2024 | marketbeat.com Get Rani Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RANI and its competitors with MarketBeat's FREE daily newsletter. Email Address Download Our Tesla Ebook For Free (Ad)Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost. To claim your copy free of charge simply follow this link. RANI Media Mentions By Week RANI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RANI News Sentiment▼0.270.46▲Average Medical News Sentiment RANI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RANI Articles This Week▼72▲RANI Articles Average Week Get Rani Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RANI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PASG News PYXS News TNGX News AURA News KRRO News TSHA News FHTX News AQST News VERV News LRMR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RANI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rani Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rani Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
